Drug Type Peptide drug conjugates |
Synonyms- |
Target |
Action modulators, inhibitors |
Mechanism BCAN modulators(Brevican core protein modulators), TOP1 inhibitors(DNA topoisomerase I inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glioma | Preclinical | China | 27 Apr 2024 |